Are Canadian Women Prepared for the Transition to Primary HPV Testing in Cervical Screening? A National Survey of Knowledge, Attitudes, and Beliefs

Author:

Haward Ben1ORCID,Tatar Ovidiu12ORCID,Zhu Patricia1ORCID,Griffin-Mathieu Gabrielle1,McBride Emily3,Waller Jo4,Brotherton Julia5,Lofters Aisha6,Mayrand Marie-Hélène27,Perez Samara89,Rosberger Zeev1910ORCID

Affiliation:

1. Lady Davis Institute for Medical Research (LDI), Jewish General Hospital, Montreal, QC H3T 1E2, Canada

2. Research Center, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada

3. Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London SE5 8AF, UK

4. Cancer Prevention Group, School of Cancer & Pharmaceutical Sciences, King’s College London, London SE1 9NH, UK

5. Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VI 3010, Australia

6. Department of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada

7. Département d’Obstétrique-Gynécologie, Université de Montréal, Montreal, QC H3C 3J7, Canada

8. Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A 3J1, Canada

9. Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada

10. Departments of Psychology and Psychiatry, McGill University, Montreal, QC H3A 1G1, Canada

Abstract

As Canadian provinces and territories prepare to transition to HPV-based primary screening for cervical cancer, failure to identify and address potential barriers to screening could hinder program implementation. We examined screening-eligible Canadians’ attitudes towards and knowledge of cervical screening. A nationally representative sample of screening-eligible Canadians (N = 3724) completed a web-based survey in the summer of 2022. Oversampling ensured that half of the sample were underscreened for cervical cancer (>3 years since previous screening or never screened). The participants completed validated scales of cervical cancer, HPV, and HPV test knowledge and HPV test and self-sampling attitudes and beliefs. Between-group differences (underscreened vs. adequately screened) were calculated for scales and items using independent sample t-tests or chi-square tests. The underscreened participants (n = 1871) demonstrated significantly lower knowledge of cervical cancer, HPV, and the HPV test. The adequately screened participants (n = 1853) scored higher on the Confidence and Worries subscales of the HPV Test Attitudes and Beliefs Scale. The underscreened participants scored higher on the Personal Barriers and Social Norms subscales. The underscreened participants also endorsed greater Autonomy conferred by self-sampling. Our findings suggest important differential patterns of knowledge, attitudes, and beliefs between the underscreened and adequately screened Canadians. These findings highlight the need to develop targeted communication strategies and promote patient-centered, tailored approaches in cervical screening programs.

Funder

Canadian Institutes of Health Research

Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Doctoral award

Fonds de Recherche du Quebec—Sante

Publisher

MDPI AG

Reference54 articles.

1. Projected estimates of cancer in Canada in 2022;Brenner;Can. Med. Assoc. J.,2022

2. (2022, June 27). Cervical Cancer Statistics. Available online: https://cancer.ca/en/cancer-information/cancer-types/cervical/statistics.

3. (2023, July 10). Cervical Cancer Screening in Canada: Monitoring & Evaluation of Quality Indicators. Available online: https://s22457.pcdn.co/wp-content/uploads/2019/01/Cervical-Cancer-Screen-Quality-Indicators-Report-2016-EN.pdf.

4. (2022, August 30). Action Plan for the Elimination of Cervical Cancer, 2020–2030. Available online: https://www.partnershipagainstcancer.ca/topics/elimination-cervical-cancer-action-plan/.

5. Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm;Tota;Prev. Med.,2017

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3